Patel Chintu

Insider Reports History

Location
Bridgewater, CA
Signature
/s/ Denis Butkovic, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patel Chintu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Amneal Pharmaceuticals, Inc. Co-CEO, Director Class A Common Stock 24,753,252 $218,818,748 $8.84 03 Mar 2025 By Family Trusts
Amneal Pharmaceuticals, Inc. Co-CEO, Director Performance-Based Restricted Stock Units 890,410 $7,871,224 $8.84 03 Mar 2025 Direct
Amneal Pharmaceuticals, Inc. Co-CEO, Director Class A Common Stock 864,033 $7,638,052 $8.84 04 Mar 2025 Direct
Amneal Pharmaceuticals, Inc. Co-CEO, Director Restricted Stock Units 277,778 $2,455,558 $8.84 04 Mar 2025 Direct

Insider Reports Filed by Patel Chintu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMRX Amneal Pharmaceuticals, Inc. 03 Mar 2025 8 -$2,814,237 4 Co-CEO, Director 05 Mar 2025, 19:31
AMRX Amneal Pharmaceuticals, Inc. 04 Mar 2024 2 $0 4 Co-CEO, Director 06 Mar 2024, 17:40
AMRX Amneal Pharmaceuticals, Inc. 07 Nov 2023 2 $0 4 Co-CEO, Director 08 Nov 2023, 18:20
AMRX Amneal Pharmaceuticals, Inc. 03 Mar 2023 1 $0 4 Co-CEO, Director 07 Mar 2023, 17:00
AMRX Amneal Pharmaceuticals, Inc. 03 Mar 2022 1 $0 4 Co-CEO, Director 03 Mar 2022, 20:19
AMRX Amneal Pharmaceuticals, Inc. 15 Dec 2021 2 +$625,500 4 Co-CEO, Director 17 Dec 2021, 15:15